RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates
RxSight, Inc. (RXST) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.50 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 14.89%. A quarter ago, it was expected that this company would post a loss of $0.52 per share when it actually produced a loss of $0.42, delivering a surprise of 19.23%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
RxSight, Inc. , which belongs to the Zacks Medical - Instruments industry, posted revenues of $20.81 million for the quarter ended June 2023, surpassing the Zacks Consensus Estimate by 8.36%. This compares to year-ago revenues of $11.36 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
RxSight, Inc. Shares have added about 137.3% since the beginning of the year versus the S&P 500's gain of 16.6%.
